Similarly, in patient-derived AML1-ETO positive primary AML cells, MTSS1 mRNA levels were significantly increased compared to human cord-blood-derived CD34+ myeloid cells (Fig 4B). This evidence concerns the gene RUNX1 and acute myeloid leukemia.